Glenmark Pharmaceuticals is set to launch affordable versions of the popular anti-diabetes and obesity drug semaglutide. This move escalate...

Indian pharmaceutical giants Sun Pharma and Glenmark are embracing Artificial Intelligence to speed up new drug creation. This technology p...

Glenmark Pharmaceuticals has received a positive report from the US health regulator. The company's manufacturing facility in Monroe, North...

Indian drugmakers Glenmark, Granules India, Sun Pharma, Zydus, and Unichem are recalling various products in the US market due to manufactu...

The company posted a consolidated net loss, from continuing operations, of 2.01 billion rupees ($24.14 million) for the three months ended ...

However, a nearly 18% rise in expenses ate into the company's core profit margin, which contracted to 29% from 30.2% a year earlier.

The study will look to enroll 158 hospitalized patients of moderate Covid-19 in India, the company added. Last month, Glenmark said it woul...

"Given complex manufacturing processes and high investments, the competition is low in the segment and typically attracts only a few player...

The company promoted by Glenn Saldanha has begun talks with some of the leading local and global drugmakers.

Delhi High Court has refused to bar Glenmark from selling the generic versions of anti-diabetic drugs manufactured by Merck Sharp & Dohme.

Drugmaker Glenmark Pharmaceuticals Ltd's quarterly profit nearly halved on heavy foreign exchange losses from overseas borrowings despite r...

Following that clearance, the deal has now become effective and Glenmark has also received the first upfront payment of USD 25 million, it ...

Ranbaxy, now owned by Japan’s Daiichi Sankyo, may get nod to sell generic version of world’s best selling drug Lipitor worth over $12 billi...

Glenmark Pharmaceuticals has completed the third phase of human trials of Crofelemer, a new drug to treat HIV-related diarrhoea that could ...

Cos opt for out-of-court settlement; Merck to refund $20-mn litigation costs.

Glenmark Generics, the generics arm of Glenmark Pharmaceuticals, on Wednesday filed the draft prospectus with Sebi to raise Rs 550-600 cror...